APELLIS PHARMACEUTICALS, INC.
Clinical trial NCT07215390 updates: 1. start date: 2025-06-23 → 2025-09-29 2. completion date: 2027-11-01 → 2028-03-23 3. primary completion date: 2027-06-01 → 2027-09-25
Clinical trial NCT07215390 updates: 1. start date: 2025-06-23 → 2025-09-29 2. completion date: 2027-11-01 → 2028-03-23 3. primary completion date: 2027-06-01 → 2027-09-25
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical